CDKN1B and prostate neoplasm: In metastasic prostate tumors, amplification of the oncogene c-myc (DeVita et al., 2011) and mutations in the genes involved in cell cycle regulation Cyclin-dependent kinase inhibitor 1B (CDKN1B) and TP53 (Baca et al., 2013) have also been reported.